全文获取类型
收费全文 | 378篇 |
免费 | 26篇 |
国内免费 | 141篇 |
出版年
2024年 | 1篇 |
2023年 | 6篇 |
2022年 | 13篇 |
2021年 | 22篇 |
2020年 | 10篇 |
2019年 | 19篇 |
2018年 | 12篇 |
2017年 | 9篇 |
2016年 | 11篇 |
2015年 | 22篇 |
2014年 | 34篇 |
2013年 | 27篇 |
2012年 | 39篇 |
2011年 | 37篇 |
2010年 | 29篇 |
2009年 | 32篇 |
2008年 | 32篇 |
2007年 | 35篇 |
2006年 | 35篇 |
2005年 | 23篇 |
2004年 | 17篇 |
2003年 | 15篇 |
2002年 | 13篇 |
2001年 | 4篇 |
2000年 | 6篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1997年 | 5篇 |
1996年 | 2篇 |
1995年 | 5篇 |
1994年 | 3篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1985年 | 1篇 |
1983年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1974年 | 1篇 |
1958年 | 3篇 |
1957年 | 2篇 |
1956年 | 3篇 |
1955年 | 1篇 |
1954年 | 2篇 |
1950年 | 1篇 |
1945年 | 1篇 |
排序方式: 共有545条查询结果,搜索用时 15 毫秒
541.
542.
Wen-Bo Kang Yu Cong Jiang-Ying Ru Si-Qi Ying Ting Zhu Dong-Sheng Wang Xiao-Wei Liu Gang Liu Jian-Ning Zhao 《Bioscience reports》2015,35(4)
Identified and cloned in 1996 for the first time, G protein-coupled oestrogen receptor (ER) 30 (GPR30/GPER) has been a hot spot in the field of sex hormone research till now. In the present study, we examined the effects of low-dose oestradiol (E2) combined with G15, a specific antagonist of GPR30 on ovariectomy (OVX)-induced osteoporosis in rats. Female Sprague–Dawley (SD) rats undergoing OVX were used to evaluate the osteoprotective effect of the drugs. Administration of E2 [35 μg/kg, intraperitoneally (ip), three times/week) combining G15 (160 μg/kg, ip, three times/week) for 6 weeks was found to have prevented OVX-induced effects, including increase in bone turnover rate, decrease in bone mineral content (BMC) and bone mineral density (BMD), damage of bone structure and the aggravation in biomechanical properties of bone. The therapeutic effect of these two drugs in combination was better than that of E2 alone. Meanwhile, the administration of G15 prevented body weight increase or endometrium proliferation in the rats. In conclusion, administration of low-dose E2 combining G15 had a satisfactory bone protective effect for OVX rats, without significant influence on body weight or the uterus. This combination therapy may be an effective supplement of drugs in prevention and treatment for postmenopausal osteoporosis. 相似文献
543.
544.
545.
Liwei Xiao Jing Liu Zongchao Sun Yujing Yin Yan Mao Dengqiu Xu Lin Liu Zhisheng Xu Qiqi Guo Chenyun Ding Wanping Sun Likun Yang Zheng Zhou Danxia Zhou Tingting Fu Wenjing Zhou Yuangang Zhu Xiao-Wei Chen John Zhong Li Shuai Chen Xiaoduo Xie Zhenji Gan 《PLoS genetics》2021,17(3)
Mitochondria are essential for maintaining skeletal muscle metabolic homeostasis during adaptive response to a myriad of physiologic or pathophysiological stresses. The mechanisms by which mitochondrial function and contractile fiber type are concordantly regulated to ensure muscle function remain poorly understood. Evidence is emerging that the Folliculin interacting protein 1 (Fnip1) is involved in skeletal muscle fiber type specification, function, and disease. In this study, Fnip1 was specifically expressed in skeletal muscle in Fnip1-transgenic (Fnip1Tg) mice. Fnip1Tg mice were crossed with Fnip1-knockout (Fnip1KO) mice to generate Fnip1TgKO mice expressing Fnip1 only in skeletal muscle but not in other tissues. Our results indicate that, in addition to the known role in type I fiber program, FNIP1 exerts control upon muscle mitochondrial oxidative program through AMPK signaling. Indeed, basal levels of FNIP1 are sufficient to inhibit AMPK but not mTORC1 activity in skeletal muscle cells. Gain-of-function and loss-of-function strategies in mice, together with assessment of primary muscle cells, demonstrated that skeletal muscle mitochondrial program is suppressed via the inhibitory actions of FNIP1 on AMPK. Surprisingly, the FNIP1 actions on type I fiber program is independent of AMPK and its downstream PGC-1α. These studies provide a vital framework for understanding the intrinsic role of FNIP1 as a crucial factor in the concerted regulation of mitochondrial function and muscle fiber type that determine muscle fitness. 相似文献